MILLIGAN DAVID V 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Jun 18, 2020
Insider Transaction Report
Form 4
MILLIGAN DAVID V
Director
Transactions
- Award
Stock Option (Right to buy)
2020-06-17+6,000→ 6,000 totalExercise: $111.06Exp: 2025-06-17→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.